These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1566739)
21. Simon Campbell on the ups and downs of drug discovery and development. Interview by Jayne Carey and Samantha Barton. Campbell S Drug Discov Today; 2005 Feb; 10(4):233-6. PubMed ID: 15708739 [TBL] [Abstract][Full Text] [Related]
22. Should Third-World countries pay the tab for new drug development? Gurwitz D Acad Med; 1999 Mar; 74(3):203. PubMed ID: 10099632 [No Abstract] [Full Text] [Related]
23. Insulin has never become a cheap generic drug in the US because of companies' small changes to "evergreen" the patent. Mayor S BMJ; 2015 Mar; 350():h1535. PubMed ID: 25794503 [No Abstract] [Full Text] [Related]
24. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1. Kuhrt K; Chace-Ortiz M IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217 [TBL] [Abstract][Full Text] [Related]
25. US government is funding fewer trials as number of industry sponsored trials grows. Dyer O BMJ; 2015 Dec; 351():h6893. PubMed ID: 26684014 [No Abstract] [Full Text] [Related]
27. Pharmaceutical innovation in the United States. Factors affecting future performance. Pollard MR Int J Technol Assess Health Care; 1993; 9(2):167-73. PubMed ID: 8458697 [TBL] [Abstract][Full Text] [Related]
28. An interview with Richard M. Eglen, Ph.D. Eglen RM Assay Drug Dev Technol; 2006 Oct; 4(5):503-9. PubMed ID: 17115921 [No Abstract] [Full Text] [Related]
29. States combat drug costs. Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442 [No Abstract] [Full Text] [Related]
30. ["Me-too drugs" and the concept of a class effect]. Blöchl-Daum B Wien Med Wochenschr; 2006 Sep; 156(17-18):494-7. PubMed ID: 17041805 [TBL] [Abstract][Full Text] [Related]
32. The economics of pediatric formulation development for off-patent drugs. Milne CP; Bruss JB Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801 [TBL] [Abstract][Full Text] [Related]
33. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related]
34. Pharmaceuticals and medical devices: cost savings. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891 [No Abstract] [Full Text] [Related]
35. Rho Chi lecture. Pharmaceutical sciences in the next millennium. Triggle DJ Ann Pharmacother; 1999 Feb; 33(2):241-6. PubMed ID: 10084422 [TBL] [Abstract][Full Text] [Related]
36. [Chemical drug development]. Castro B Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592 [No Abstract] [Full Text] [Related]
37. Can complexity be commercialized? Mack GS Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456 [No Abstract] [Full Text] [Related]
38. Taking the lead? Hird N Drug Discov Today; 2003 Apr; 8(7):292-3. PubMed ID: 12654539 [No Abstract] [Full Text] [Related]
39. Managed care and a changing pharmaceutical industry. Pollard MR Health Aff (Millwood); 1990; 9(3):55-65. PubMed ID: 2227785 [No Abstract] [Full Text] [Related]
40. A few specialty drug prices fall--all generics. Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]